Company invites individual and institutional investors to log-on to VirtualInvestorConferences.com to view
presentation
SAN RAMON, Calif., Dec. 5, 2016 /PRNewswire/ -- Galena
Biopharma Inc. (NASDAQ: GALE), a biopharmaceutical company committed to the development and commercialization of hematology and
oncology therapeutics that address unmet medical needs, today announced that the December 1,
2016 presentation from Mark W. Schwartz, Ph.D., President and Chief Executive Officer, is
now available for on-demand viewing at VirtualInvestorConferences.com.
LINK: http://tinyurl.com/0602postpr
Galena Biopharma Inc.'s presentation will be available for 90 days. Interested parties may download shareholder materials from
the "virtual trade booth" for the next three weeks.
Learn more about the event at www.VirtualInvestorConferences.com.
About Galena Biopharma Inc.
Galena Biopharma Inc. is a biopharmaceutical company committed to the development and commercialization of hematology and
oncology therapeutics that address unmet medical needs. Galena's pipeline consists of multiple mid-to-late-stage clinical assets
led by our hematology asset, GALE-401, and our novel cancer immunotherapy programs including NeuVax™ (nelipepimut-S), and GALE-301/GALE-302. For more information,
please visit our website at https://galenabiopharma.com/
About VirtualInvestorConferences.com
Since 2010, VirtualInvestorConferences.com, created by BetterInvesting (NAIC) and PRNewswire, has
been the only monthly virtual investor conference series that provides an interactive forum for presenting companies to meet
directly with investors using a graphically-enhanced online platform.
Designed to replicate the look and feel of location-based investor conferences, Virtual Investor Conferences unites PR
Newswire's leading-edge online conferencing and investor communications capabilities with BetterInvesting's extensive retail
investor audience network.
Logo - http://photos.prnewswire.com/prnh/20160129/327291LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/galena-biopharma-inc-presentation-now-available-for-on-demand-viewing-300372476.html
SOURCE Galena Biopharma Inc.